{"result": {"id": "6d300469-4697-4bbc-955b-f50d52039e93", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**维拉帕米（Verapamil）** 是一种药物，具有多种药理作用和药物相互作用。作为P-糖蛋白（P-gp）抑制剂，维拉帕米能够抑制P-gp介导的药物外排，从而增加某些药物的血药浓度。例如，它可以显著提高秋水仙碱（colchicine）和达比加群酯（dabigatran etexilate）的浓度，可能导致这些药物的毒性风险增加，如秋水仙碱中毒或达比加群相关的出血风险。  \n\n此外，维拉帕米与其他药物联用时可能产生协同或不良作用。与美托洛尔（metoprolol）合用时，两者对心脏传导系统和窦房结功能的抑制作用可能叠加，导致心动过缓、低血压等不良反应。同时，维拉帕米与辛伐他汀（simvastatin）联用时会抑制辛伐他汀的代谢，增加肌病（如肌肉疼痛、无力）和横纹肌溶解症的风险，因此需谨慎调整剂量或避免联合使用。  \n\n综上所述，维拉帕米在临床应用中需密切监测其与其他药物的相互作用，尤其是P-gp底物药物（如秋水仙碱、达比加群酯）以及经CYP3A4代谢的药物（如辛伐他汀），同时注意其对心血管系统的叠加效应（如与美托洛尔的联用）。合理用药可减少不良反应并确保治疗效果。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752167531, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 299, "prompt_tokens": 240, "total_tokens": 539, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 176}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"维拉帕米\"\nDescription List: [\"Verapamil is a P-gp inhibitor that can increase colchicine levels\", \"Verapamil is a P-gp inhibitor that increases dabigatran etexilate concentrations\\\"\", \"维拉帕米是一种药物，与美托洛尔合用时可能对心脏传导和窦房结功能产生相加的抑制作用，导致心动过缓和血压下降>\", \"维拉帕米是一种药物，与辛伐他汀合用会增加肌病和横纹肌溶解症风险\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_bcb0b12c2eb4a947740e4342beeef83b1f5e0697f279ffd3edd62a0fe185a146_v2"}